Abstract
A Los Angeles investigator's study of families with erythropoietic protoporphyria (EP), an inherited photocutaneous disorder first described in 1961, suggests there are two sites for abnormal protoporphyrin formation; one is erythropoietic and the other probably hepatic. The two sites apparently can function independently of each other. "The hepatic site appears to be the source of the increased plasma protoporphyrin which seems requisite for photosensitivity to occur," Allan G. Redeker, MD, Department of Medicine, University of Southern California Medical School, told the American College of Physicians. Redeker said that protoporphyrin has been found in the plasma of all his EP patients "and seems clearly to be the photosensitizing agent." In one EP family, in which fraternal twin boys have the disease, the mother, who has never had a cutaneous lesion, does, however, have a large increase in her fecal protoporphyrin excretion. "This apparent evidence of a latent trait suggests a dissociation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
